NCT01891292View on ClinicalTrials.gov

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2015

Conditions
MicroalbuminuriaSickle Cell Nephropathy
Interventions
DRUG

Enalapril

0.25-0.35 mg/kg/day

DRUG

N-Acetylcysteine

N-Acetylcysteine 0.5 mmol/kg

Trial Locations (1)

Unknown

Sickle Cell Unit, Kingston

Sponsors
All Listed Sponsors
collaborator

Caribbean Health Research Council

OTHER

lead

The University of The West Indies

OTHER